If you’ve invested in generating data sets, why would you keep them to yourself? I think data sharing and open data is really important for the whole scientific society. I think there is great value in collaboration.
I think nobody wants to re-invent the wheel which is already there. We make our data accessible, we make our results accessible, and we also make our technology accessible. It saves time to use the data that is publicly available, it saves money, too.
And there is such a power in the data collaboration because that increases confidence in the results. So the first step in this process is we typically pre-print our papers on a website called bioRxiv - it's a paper repository. This is completely open access, and it’s slightly nerve-wracking.
You finalize your manuscript, you hit submit and within a few hours that is completely open to the public. And that is quite a new concept. You sometimes get a lot of interest on Twitter - a lot of debate, discussion about your paper - so you get immediate feedback.
So it can be completely nerve-wracking, but it's also extremely satisfying as well, knowing that you are making your work available immediately. There’s not an 18-month delay before the public see the work I think it’s the worst thing if you develop something new and then nobody will use it because they can’t access it. So for us, it’s really to give us a wider reach, to enable people to use it.
So that’s why we release as much as we can when we publish. It changes the field of cancer research. Because, again, with this kind of data availability, all the computational modelers can access this data freely.
They can easily get into this field and bring new models, bring new insights to this data. They can work together collaboratively with cancer biologists to get new insights, to get, you know, better prediction capability. I think our main aim is to find cures for diseases.
In my research, I have shared within WashU my code and my data. And I have also used peoples’ data within the campus. If I can go ahead and download data or use the data that has already been analyzed, the entire idea is that - so that people can go ahead and save their time and and gain knowledge from the data that has already been used.
We developed a technology to apply our questions on stem cell biology, so a very specific area. But people are seeing the opportunity to apply this technology to cancer biology questions, developmental biology questions, and this is giving us direct feedback. Because they’re saying to us, “Hey, it works in this system, and this is what we’re finding.
” And then other people are telling us, you know, "We’re finding this issue with the technology, it doesn't translate very well to this system. ” And that’s giving us ideas and inspiration for how we can tweak our technology so it works in a more broadly applicable way. And I also think that the future trend is to have more of this collaborative effort and make precision medicine a reality.
Ultimately as scientists, we should be trying to make an impact; we should be trying to move the process of discovery forward. Reproducing each other’s results and hoping we have cures for diseases like cancer. Then eventually, I think, we'll have better prediction models, better technologies to help our patients.
So, why wouldn't we? Why wouldn’t we share our findings? I would definitely like to see this whole process expanded of open-source, public data.
And I’m very happy that I am working in this age of where this is actively evolving, and I’m happy to do my part.